DermaValue vs CRUSE Control Urticaria Utilisation & Stats

DermaValue was developed by dermatologists and scientists from the University Medical Center Hamburg/Germany and the German Network for psoriasis (PsoNet) lead by Professor Matthias Augustin. DermaValue was requested by national and international societies for dermatology in order to support clinical practice and patient care. DermaValue offers doctors and patients a fast and personalized access to electronic outcome measures in skin diseases. The tools are provided web-based and by a multi-platform app. By using our platform, individual patient medical data can be saved and managed at any time. Patients can select the tools individually, fill out the forms, save results, follow treatment and monitor outcomes. The results permit doctors to get a more precise overview of the development of their patient condition. It doesn't aim to replace a visit to a doctor, rather complement it.

Apple App Store
Gratuit
Médical

Classement dans le store

- -

CRUSE Control Urticaria

CRUSE® is an APP developed by renowned dermatologists and allergoligists to help patients with Chronic Urticaria manage their condition. Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day. Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician. Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you. Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres. Are you a physician? Find out more on www.cruse-control-com